Skin ElementsASX:SKN +20.00% EBITDA Margin % is -2,152.17% as of Dec. 2025. The stock has 3 warning signs investors should review. Among 1,953 Consumer Packaged Goods companies, Skin Elements ranks worse than 99.23% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Skin Elements's EBITDA for the
six
months ended in Dec. 2025 was A$-3.96 Mil. Skin Elements's Revenue for the
six
months ended in Dec. 2025 was A$0.18 Mil. Therefore, Skin Elements's EBITDA margin for the quarter that ended in Dec. 2025 was -2,152.17%.
Skin Elements (ASX:SKN) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Skin Elements EBITDA Margin % Related Terms
Skin Elements EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Skin Elements's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:SKN vs PG, CL, KVUE: EBITDA Margin % Comparison
For the Household & Personal Products subindustry, Skin Elements's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Skin Elements EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Skin Elements's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Skin Elements's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Skin Elements (ASX:SKN) has a EBITDA Margin % of -2,152.17% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Skin Elements and its competitors. According to the industry distribution chart, Skin Elements ranks #1938 out of 1953 companies in the Consumer Packaged Goods industry, placing it in the top 99.2%.
Is Skin Elements' EBITDA Margin % too high?
Skin Elements' current EBITDA Margin % is -2,152.17%. Based on the distribution chart, Skin Elements ranks #1938 out of 1953 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does Skin Elements' EBITDA Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Skin Elements ranks #1938 out of 1953 companies for EBITDA Margin %. This places Skin Elements in the lower half of its industry. The industry median EBITDA Margin % is 8.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.99, based on 1,953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Skin Elements and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Skin Elements's current EBITDA Margin % is -2,152.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skin Elements stock overvalued right now?
Skin Elements (ASX:SKN) has a current EBITDA Margin % of -2,152.17%. The current EBITDA Margin % is -2,152.17%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Skin Elements (ASX:SKN), the current EBITDA Margin % is -2,152.17% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Skin Elements Ltd is a company that operates in the beauty and personal care industry. The principal business activities include the manufacture and distribution of natural, organic, health, and wellness products. Its brand portfolio includes Soleo Organics natural sunscreen brand, the PapayaActivs therapeutic skincare range, Elizabeth Jane Natural Cosmetics, and the recently developed Invisi-Shield SuprCuvr plant-based hospital-grade disinfectant range. The company has a single segment being research and development of the inventive proprietary SE Formula biotechnology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:SKN has been successfully added to your 